ADVENTRX: Upcoming News Event and Very Positive Technical Analysis |
|
|
| By M.E.Garza |
| Thursday, 17 December 2009 09:45 |
|
They have a great looking chart and some upcoming news events that will likely see it trading higher in the coming days- especially one that involves the submission of an NDA (new drug application) before the end of the year and two late stage programs that are promising high-return on investment. ADVENTRX Pharmaceuticals, Inc.(AMEX:ANX) As always, do your own DD. This is an AMEX stock that trades before and after market hours.
Disclosure: long ANX BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section Add this page to your favorite Social Bookmarking websites |
about 1 hour ago
NHS education reforms 'lack detail' http://t.co/YiUKVEsS
about 1 hour ago
Molecular 'on-off' switch for Parkinson's disease discovered http://t.co/wZ1N0xhq
about 1 hour ago
Alnylam and PBL Sign License Agreement for Baulcombe & Hamilton RNAi Patent http://t.co/CnJ8fKok
about 1 hour ago
Roche's dalcetrapib failure fuels HDL debate, but CETP not done yet http://t.co/8H9JRnp9
about 1 hour ago
Modest Gains Vanish As Stocks Reverse Lower http://t.co/AXlpfiAP
about 1 hour ago
Reading: One More Reason the Market's Pullback is Not Over http://t.co/iSZ0oYUq
about 8 hours ago
Novo’s Insulin Pill Quest is Holy Grail for Novo: Health http://t.co/1NixK9Mx
about 8 hours ago
Bayer's Nexavar fails in lung cancer but FDA staff keen on Xarelto for ACS http://t.co/9VZRVqqD


















